Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 7Ovarian Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Pancreatic Neoplasms 1Motor Activity 1Lung Neoplasms 1Kidney Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1

Interventions

pembrolizumab 6sargramostim 5Psychiatric Rehabilitation 5Early Intervention, Educational 5Magnetic Resonance Spectroscopy 4Gemcitabine 4Cyclophosphamide 4palbociclib 3Trastuzumab 3Therapeutics 3Standard of Care 3Radiotherapy 3Oxaliplatin 3Methods 3Irinotecan 3Interferon-alpha 3Fluorouracil 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Docetaxel 3Bortezomib 3temsirolimus 2motexafin gadolinium 2entinostat 2cemiplimab 2cediranib 2Specimen Handling 2Radiosurgery 2Practice Guidelines as Topic 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Behavior Therapy × Genitourinary × Clear all
NCT04902144 2023-06-09

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Fred Hutchinson Cancer Center

Phase NA Completed
6 enrolled 8 charts
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡